Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Arjuna Therapeutics Logo
Arjuna Therapeutics Growth Score
75
CB Rank
382129
Heat Score
48
Arjuna Therapeutics is a new medical platform to help patients defeat the worst kinds of a cancer diagnosis.
Founded
obfuscation
Private A Coruña, Galicia, Spain1-10 arjunatherapeutics.com/
Health Care
Oncology
Pharmaceutical
Overview

Arjuna Therapeutics
Growth Score
75
Heat Score
48

Growth Score75
-17 pts
in past quarter
Heat Score 48
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Arjuna Therapeutics

CB Rank
382129
Arjuna Therapeutics is a new medical platform to help patients defeat the worst kinds of a cancer diagnosis.
Founded
obfuscation
Private A Coruña, Galicia, Spain1-10 arjunatherapeutics.com/
Health Care
Oncology
Pharmaceutical

Key People

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Insight

See this Growth Insight
Arjuna Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Ag5
A small molecule drug designed to deactivate mitochondrial antioxidants in cancer cells to extend patient lifespan in clinical stage cancers.
Therapeutic Molecular Clusters (TMCs)
A class of medicines acting as catalysts within cells to influence reactions without being consumed, targeting cancer vulnerabilities.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 5 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Feb 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

3Arjuna Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 5m.

Total IP

2Arjuna Therapeutics has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Arjuna Therapeutics's headquarters? Arjuna Therapeutics is located in A Coruña, Galicia, Spain.Who are Arjuna Therapeutics's competitors? Alternatives and possible competitors to Arjuna Therapeutics may include Whitehawk Therapeutics, Amgen, and  Relay Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|